510(k) K002376
K002376 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY". The FDA issued a decision of Substantially Equivalent on Oct 26, 2000. The device falls under product code LTJ (Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers), a Class II device regulated under 21 CFR 866.6010. Bayer Corp. has 95 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 26, 2000
- Date Received
- Aug 4, 2000
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Bayer Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.